Sawamoto A - Search Results

1

Clinical significance of minimal residual disease in patients with t(8;21) acute myeloid leukemia in Japan.

Narimatsu H, Iino M, Ichihashi T, Yokozawa T, Hayakawa M, Kiyoi H, Takeo T, Sawamoto A, Iida H, Tsuzuki M, Yanada M, Naoe T, Suzuki R, Sugiura I. Narimatsu H, et al. Among authors: sawamoto a. Int J Hematol. 2008 Sep;88(2):154-158. doi: 10.1007/s12185-008-0108-1. Epub 2008 Jun 17. Int J Hematol. 2008. PMID: 18553224

2

[Efficacy and safety of induction chemotherapy consisting of anthracycline for 3 days and cytarabine for 7 days in elderly patients with acute myeloid leukemia].

Kurahashi S, Iwasaki T, Suzuki H, Sawamoto A, Sugimoto T, Narimatsu H, Adachi T, Hayakawa F, Sugiura I. Kurahashi S, et al. Among authors: sawamoto a. Gan To Kagaku Ryoho. 2007 Oct;34(10):1617-21. Gan To Kagaku Ryoho. 2007. PMID: 17940376 Japanese.

3

[Frequency and prognostic value of chromosome abnormalities in multiple myeloma].

Kurahashi S, Sawamoto A, Sugimoto T, Narimatsu H, Iwasaki T, Adachi T, Suzuki H, Hayakawa F, Sugiura I. Kurahashi S, et al. Among authors: sawamoto a. Rinsho Ketsueki. 2007 Nov;48(11):1455-61. Rinsho Ketsueki. 2007. PMID: 18080502 Japanese.

4

Clinical characteristics and outcomes in patients with t(8;21) acute myeloid leukemia in Japan.

Narimatsu H, Yokozawa T, Iida H, Tsuzuki M, Hayakawa M, Takeo T, Iino M, Ichihashi T, Kato C, Sawamoto A, Sao H, Yanada M, Emi N, Kiyoi H, Yamaguchi T, Naoe T, Suzuki R, Sugiura I. Narimatsu H, et al. Among authors: sawamoto a. Leukemia. 2008 Feb;22(2):428-32. doi: 10.1038/sj.leu.2404905. Epub 2007 Aug 16. Leukemia. 2008. PMID: 17713551 No abstract available.

5

[Analysis of high-risk multiple myeloma patients treated with high-dose chemotherapy].

Kurahashi S, Suzuki K, Sawamoto A, Adachi T, Iwasaki T, Suzuki H, Sugimoto T, Narimatsu H, Hayakawa F, Sugiura I. Kurahashi S, et al. Among authors: sawamoto a. Rinsho Ketsueki. 2010 Mar;51(3):174-80. Rinsho Ketsueki. 2010. PMID: 20379111 Japanese.

6

Long-term remission after autologous peripheral blood stem cell transplantation for relapsed intravascular lymphoma.

Sawamoto A, Narimatsu H, Suzuki T, Kurahashi S, Sugimoto T, Sugiura I. Sawamoto A, et al. Bone Marrow Transplant. 2006 Jan;37(2):233-4. doi: 10.1038/sj.bmt.1705220. Bone Marrow Transplant. 2006. PMID: 16284609 No abstract available.

7

Cloperastine Reduces IL-6 Expression via Akt/GSK3/Nrf2 Signaling in Monocytes/Macrophages and Ameliorates Symptoms in a Mouse Sepsis Model Induced by Lipopolysaccharide.

Kawamura A, Sawamoto A, Okuyama S, Nakajima M. Kawamura A, et al. Among authors: sawamoto a. Biol Pharm Bull. 2024;47(10):1699-1707. doi: 10.1248/bpb.b24-00472. Biol Pharm Bull. 2024. PMID: 39443088 Free article.

8

Benproperine reduces IL-6 levels via Akt signaling in monocyte/macrophage-lineage cells and reduces the mortality of mouse sepsis model induced by lipopolysaccharide.

Kawamura A, Ito A, Takahashi A, Sawamoto A, Okuyama S, Nakajima M. Kawamura A, et al. Among authors: sawamoto a. J Pharmacol Sci. 2024 Oct;156(2):125-133. doi: 10.1016/j.jphs.2024.08.001. Epub 2024 Aug 3. J Pharmacol Sci. 2024. PMID: 39179331 Free article.

9

[An Investigation of Substances Influencing Adipocyte Function].

Sawamoto A. Sawamoto A. Yakugaku Zasshi. 2024;144(8):799-804. doi: 10.1248/yakushi.24-00091. Yakugaku Zasshi. 2024. PMID: 39085056 Free article. Review. Japanese.

10

Tipepidine activates AMPK and improves adipose tissue fibrosis and glucose intolerance in high-fat diet-induced obese mice.

Sawamoto A, Okada M, Matsuoka N, Okuyama S, Nakajima M. Sawamoto A, et al. FASEB J. 2024 Mar 15;38(5):e23542. doi: 10.1096/fj.202301861RR. FASEB J. 2024. PMID: 38466234

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

40 results

Search Page

Filters